Overview

A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants

Status:
Completed

Trial end date:
2024-01-04

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to assess the palatability and compare acceptability of brensocatib oral solutions.

Phase:

Phase 1

Details

Lead Sponsor:

Insmed Incorporated